rs55872908

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001122752.2(SERPINI1):​c.838G>A​(p.Ala280Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0162 in 1,613,532 control chromosomes in the GnomAD database, including 272 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.011 ( 16 hom., cov: 32)
Exomes 𝑓: 0.017 ( 256 hom. )

Consequence

SERPINI1
NM_001122752.2 missense

Scores

1
2
15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 7.66
Variant links:
Genes affected
SERPINI1 (HGNC:8943): (serpin family I member 1) This gene encodes a member of the serpin superfamily of serine proteinase inhibitors. The protein is primarily secreted by axons in the brain, and preferentially reacts with and inhibits tissue-type plasminogen activator. It is thought to play a role in the regulation of axonal growth and the development of synaptic plasticity. Mutations in this gene result in familial encephalopathy with neuroserpin inclusion bodies (FENIB), which is a dominantly inherited form of familial encephalopathy and epilepsy characterized by the accumulation of mutant neuroserpin polymers. Multiple alternatively spliced variants, encoding the same protein, have been identified. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008110166).
BP6
Variant 3-167794781-G-A is Benign according to our data. Variant chr3-167794781-G-A is described in ClinVar as [Benign]. Clinvar id is 344131.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-167794781-G-A is described in Lovd as [Benign]. Variant chr3-167794781-G-A is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0109 (1652/152180) while in subpopulation NFE AF= 0.0172 (1168/68016). AF 95% confidence interval is 0.0164. There are 16 homozygotes in gnomad4. There are 754 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1652 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SERPINI1NM_001122752.2 linkuse as main transcriptc.838G>A p.Ala280Thr missense_variant 5/9 ENST00000446050.7 NP_001116224.1
SERPINI1NM_005025.5 linkuse as main transcriptc.838G>A p.Ala280Thr missense_variant 5/9 NP_005016.1
SERPINI1XM_017006618.3 linkuse as main transcriptc.838G>A p.Ala280Thr missense_variant 5/9 XP_016862107.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SERPINI1ENST00000446050.7 linkuse as main transcriptc.838G>A p.Ala280Thr missense_variant 5/91 NM_001122752.2 ENSP00000397373 P1
SERPINI1ENST00000295777.9 linkuse as main transcriptc.838G>A p.Ala280Thr missense_variant 5/91 ENSP00000295777 P1

Frequencies

GnomAD3 genomes
AF:
0.0109
AC:
1652
AN:
152062
Hom.:
16
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00341
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00859
Gnomad ASJ
AF:
0.0303
Gnomad EAS
AF:
0.000386
Gnomad SAS
AF:
0.00956
Gnomad FIN
AF:
0.00301
Gnomad MID
AF:
0.0222
Gnomad NFE
AF:
0.0172
Gnomad OTH
AF:
0.00909
GnomAD3 exomes
AF:
0.0114
AC:
2856
AN:
251164
Hom.:
27
AF XY:
0.0117
AC XY:
1590
AN XY:
135746
show subpopulations
Gnomad AFR exome
AF:
0.00351
Gnomad AMR exome
AF:
0.00561
Gnomad ASJ exome
AF:
0.0276
Gnomad EAS exome
AF:
0.000109
Gnomad SAS exome
AF:
0.0102
Gnomad FIN exome
AF:
0.00370
Gnomad NFE exome
AF:
0.0162
Gnomad OTH exome
AF:
0.0145
GnomAD4 exome
AF:
0.0168
AC:
24532
AN:
1461352
Hom.:
256
Cov.:
32
AF XY:
0.0165
AC XY:
11984
AN XY:
726960
show subpopulations
Gnomad4 AFR exome
AF:
0.00287
Gnomad4 AMR exome
AF:
0.00644
Gnomad4 ASJ exome
AF:
0.0292
Gnomad4 EAS exome
AF:
0.000101
Gnomad4 SAS exome
AF:
0.0105
Gnomad4 FIN exome
AF:
0.00412
Gnomad4 NFE exome
AF:
0.0190
Gnomad4 OTH exome
AF:
0.0180
GnomAD4 genome
AF:
0.0109
AC:
1652
AN:
152180
Hom.:
16
Cov.:
32
AF XY:
0.0101
AC XY:
754
AN XY:
74384
show subpopulations
Gnomad4 AFR
AF:
0.00340
Gnomad4 AMR
AF:
0.00858
Gnomad4 ASJ
AF:
0.0303
Gnomad4 EAS
AF:
0.000387
Gnomad4 SAS
AF:
0.00977
Gnomad4 FIN
AF:
0.00301
Gnomad4 NFE
AF:
0.0172
Gnomad4 OTH
AF:
0.00900
Alfa
AF:
0.0153
Hom.:
25
Bravo
AF:
0.0113
TwinsUK
AF:
0.0159
AC:
59
ALSPAC
AF:
0.0200
AC:
77
ESP6500AA
AF:
0.00386
AC:
17
ESP6500EA
AF:
0.0195
AC:
168
ExAC
AF:
0.0112
AC:
1354
Asia WGS
AF:
0.00462
AC:
16
AN:
3478
EpiCase
AF:
0.0174
EpiControl
AF:
0.0165

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, Amsterdam University Medical Center-- -
not provided Benign:2
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsDec 17, 2018- -
Familial encephalopathy with neuroserpin inclusion bodies Benign:2
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 30, 2024- -
SERPINI1-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesJun 05, 2024This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.30
T
BayesDel_noAF
Benign
-0.19
CADD
Benign
21
DANN
Benign
0.90
DEOGEN2
Benign
0.11
T;T
Eigen
Benign
-0.25
Eigen_PC
Benign
-0.041
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Benign
0.82
.;T
MetaRNN
Benign
0.0081
T;T
MetaSVM
Benign
-0.64
T
MutationAssessor
Benign
0.14
N;N
MutationTaster
Benign
1.0
D;D;D
PrimateAI
Uncertain
0.56
T
PROVEAN
Benign
0.56
N;N
REVEL
Uncertain
0.50
Sift
Benign
0.55
T;T
Sift4G
Benign
0.56
T;T
Polyphen
0.094
B;B
Vest4
0.12
MPC
0.13
ClinPred
0.019
T
GERP RS
5.7
Varity_R
0.62
gMVP
0.37

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs55872908; hg19: chr3-167512569; API